Meetings for Clinical Investigation—isolation Or Integration?**Presidential Address-The Twenty-ninth Annual Meeting of the Society for Investigative Dermatology, Inc., June 16, 1968, San Francisco, Calif.  by Lernee, Aaron B.
There is no shortage of meetings, large or
small, in biology and medicine. Yet for re-
search groups within clinical departments or
for the clinical investigator a unique hiatus
exists. An investigator in one specialty can-
not meet simultaneously with investigators in
other specialties. Before anyone objects to
this statement, let me elaborate. The basic sub-
jects in the life sciences—for example, bio-
chemistry, physiology, immunology, pharma-
cology, experimental pathology, and nutrition
—are represented at a very large annual
meeting held under an affiliation entitled
Federation of American Societies for Experi-
mental Biology. This meeting, made up of six
independent societies, is criticized routinely
for its hugeness—some 21,000 biologists at-
tended the 1968 meeting in Atlantic City this
spring. But the numerous advantages of such a
meeting far outweigh the one disadvantage
of size. People with mutual interests can get
together once a year. Symposia are held, re-
search papers presented, technical exhibits
shown; and there is a placement center. For
those at the other end of the spectrum in the
life sciences, namely, practioners of medicine,
an analogous meeting is held each year by
the AMA. Again the disadvantage of the large
attendance at the meeting, about 15,000 is off-
set by the numerous advantages made possible
when clinicians from several branches of medi-
cine are able to meet on a common ground.
Most groups—basic scientists, clinical investi-
gators and clinicians—have small specialized
meetings or discussion groups throughout the
year.
Why is there no single meeting place for
all clinical investigators? The disadvantage of
its potentially large size is not the reason
* Presidential Address—The Twenty-ninth An-
nual Meeting of the Society for Investigative
Dermatology, Inc., June 16, 1968, San Francisco,
Calif.
1 Section of Dermatology, Department of In-
ternal Medicine, Yale University School of Medi-
cine, New Haven, Connecticut.
This address is being published simultaneously
in Clinical Research.
309
such a meeting doesn't exist. The answer lies
in the unfortunate evolution of clinical in-
vestigative groups. To understand the prob-
lem and to find a solution, we have to know
how the major groups representing internal
medicine developed, namely, the Association of
American Physicians, AAP, the American
Society for Clinical Investigation, ASCI, and
the American Federation for Clinical Re-
search, AFCR. These independent yet emo-
tionally united groups meet at overlapping
times each year usually in Atlantic City. The
membership although not restricted to people
in internal medicine, probably consists of over
90% internists. About 3,000 people attend
the annual meeting. Other specialty groups, for
example, pediatrics, dermatology, ophthalmol-
ogy, etc., have their own meetings for their
investigators. The reasons for knowing the
background of internal medicine's investigative
groups are obvious. Internal medicine is usu-
ally the largest clinical department in a medi-
cal school. The people in that department most
often exert the leadership for clinical research
at the school. Their research societies are larger
than those of others. They have a long history.
They have been successful. It is easy to see why
they believe they are self-sufficient. Although no
attempt was made for their societies to be ex-
clusive and restricted to internists, no effort was
subsequent development of independent societies
This approach, I am sure, was responsible for the
subsequent development of independent socities
by all the other specialty groups. It was appar-
ent that if members of a specialty, such as der-
matology, wanted their research people to get
together they had better find the ways and
means to do it themselves. No outside direction
or stimulus was available.
In 1959 Dr. Philip K. Bondy, then editor
of the Journal of Clinical Investigation, ar-
ranged for Mrs. Ellen R. Brainard, a member
of the editorial secretarial staff, to write the
history of the ASCI to mark its 50th anni-
versary. Mrs. Brainard's lucid account of the
development of this astute society should be
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read by all interested in meetings for clinical
investigation (1). The Association of American
Physicians, AAP, was formed before 1900 by
men in academic and investigative medicine.
After the turn of the century younger investi-
gators had little opportunity to present papers
because few belonged to the AAP. The mem-
bersbip of tbat organization was limited.
Samuel J. Meltzer, 61 years ago almost to the
day, and at an AMA meeting (in Atlantic
City), suggested the formation of a new society
which would give younger men the advantage
of meeting with other physicians active in re-
search. Two years later, on May 10, 1909, the
first meeting was held with the 58 year old
Meltzer as president. Dr. Meltzer gave up a
large medical practice in New York City in
1904 to become head of the Department of
Physiology and Pharmacology at the Rockefel-
ler Institute for Medical Research. A year
earlier he helped found the Society for Ex-
perimental Biology and Medicine. The new or-
ganization, which later became known as the
American Society for Clinical Investigation or
the Young Turks, flourished. But by 1921
Meltzer had to face the same problem as be-
fore. He saw the membership of the ASCI
growing old. Again he wanted a new society
composed of younger men. But such a change,
brought about by others after his death, was
not made until 1941 when the American
Federation for Clinical Research was formed.
In the twenties the ASCI grew, and restric-
tion of the number of members was considered
necessary. In 1924 active membership was
limited to 200. In 1930 it was decided to
keep the society in the hands of younger men,
and an age limit of 45 was set for active
membership. In the relatively new American
Federation for Clinical Research, AFCR, an
age limit of 40 was imposed for active mem-
bership, but the Dumber of members was not
restricted.
Because the people in these three organiza-
tions are largely of one specialty, and be-
cause one strives to advance his membership
from the nonrestrictive AFCR to the ASCI and
then the AAP, the caste system works. Cer-
tainly there is no evidence of sage planning
to help investigators in other branches of medi-
cine get together. Structures preoccupied with
age factors and stiff membership restrictions
could not offer the leadership for joint meet-
ings with investigators in other specialties. Only
this year Robert A. Good, a pediatrician and
president of the ASCI, recommended eliminat-
ing numerical restriction of members. If two
people are equally qualified for membership,
it makes little sense to accept only one just
because once upon a time it was decided to
keep the organization relatively small.
The pediatricians developed their organiza-
tions in a similar fashion. Each year and usu-
ally in Atlantic City just before the assembly
of internists, two independent pediatric societies
join for a common meeting. One is the American
Pediatric Society, the more senior group. The
other is the Society for Pediatric Research
which has a 45 year age limit. About 2,200
physicians were at their last meeting.
What about us? We are not in an ideal
position to criticize others because we have
made our own mistakes. We started late, only
31 years ago. The leadership decided to hold
the meetings just prior to the AMA conven-
tion. Thus at the beginning we were directed
away from other investigative groups. Later
the association with the AMA became closer
when it was decided to run the Investigative
Society meetings side by side with the derma-
tology section of the AMA. This arrangement
helped the investigative society a little and the
dermatology section of the AMA a lot. Never-
theless, the direction still was wrong. It matters
not how one rationalizes on this subject; the
fact is that it is important for the people doing
investigative work in dermatology to meet
with investigators in other branches of medicine.
In like manner people interested in the clinical
aspects of dermatology should meet with clini-
cians in other disciplines. If the Society for
Investigative Dermatology moves its annual
meeting to coincide with those held by the
internists and pediatricians, we shall be taking
a step forward for ourselves.
Aside from the point of self-interest, I want
to comment on the broader picture of the
clinical investigator regardless of his branch of
medicine. The time is ripe and the need great
for investigators in diverse medical fields to
have some type of meeting that unites several
specialties. The large size of such a meeting
with the decrease in togetherness resulting from
more than one specialty's being represented
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would not be sufficient reason for holding back
the union. Look at the advantages of a com-
mon mecting. Overlapping of research interests
would make the meeting more efficient than
those we have now. For example, it is easy
to see that papers on connective tissue would
be given to a group of research dermatologists.
But other people in medicine also are interested
in connective tissue. The interchange of ideas
among individuals from different specialties
could only increase the interest in and the ex-
citement of research problems. In addition the
clinical investigator would have an important
administrative body to help support the ma-
jority views in the many fields concerned with
funds for research and teaching activities.
How can such a change come about? I am
going to suggest three possibilities. A few years
ago Dr. Irvine H. Page proposed that there
be a National Academy of Medicine compara-
ble to the National Academy of Sciences. Now
the National Academy of Sciences has a com-
mittee with Dr. Walsh McDermott as chair-
man to study the desirability of forming a
National Academy of Medicine. If such an
organization existed as part of the National
Academy of Science or independently, it could
look into the problem of meetings for clinical
investigators from several medical specialties.
It would be important to have advice not only
from the officers of the various medical re-
search groups but also from research people
outside of medicine and biology. Surely an in-
dependent appraisal of the problems and needs
as well as suggestions for their solution would
benefit many people. Action could be taken on
the recommendations of the committee.
Recently Dr. Robert H. Williams success-
fully organized representatives of some of the
clinical research societies into a group called
Research Societies Council. Already this group
is exclusive. A request from the Society of
Investigative Dermatology to be represented
was set aside. The Research Societies Council
is not concerned primarily with the individual
investigator but rather with overall administra-
tive functions, particularly in activities of the
federal government.
The second approach and one that could be
followed with a minimum of disruption would
involve moving the meetings of dermatology
away from the AMA to those of internal mcdi-
eioe and pediatrics. The internal medicine
groups have in recent years met in Atlantic
City. In the future some meetings will be held
elsewhere. The pediatric organizations generally
meet just before the internal medicine groups
and again usually in Atlantic City. However,
occasionally they meet at other locations. If
the dermatologists and pediatricians assembled
immediately before the internists, it would not
be easy for a physician to stay for both meet-
ings. Too many days would be involved. How-
ever, if satisfactory hotel accommodations could
be found so that the dermatologists and pedia-
tricians could meet at exactly the same time
as the internists, I am sure that soon there
would be a brochure giving the programs of all
the meetings. The opportunity would then be
ripe for a federation of internists, pediatricians
and dermatologists. Others would follow.
My third suggestion, although the least likely
to be used, is the one that might be an in-
stantaneous success. I offer it as a challenge
that will test the daring of the younger people
involved in clinical research. At present the
largest investigative group is the American
Federation for Clinical Research. Their age
limit is 40. Others like myself can belong but
cannot hold office or present a paper. Almost
anyone with an MD degree seriously interested
in research can be an active member. The
society belongs to the common man in re-
search and in this sense is unlike the ASCI
and the AAP which are prestigious groups.
Because of the large size, the AFCR has muscle
—much more than its officers realize. How-
ever, the general atttitude prevails that the
society must be run by youth and, at the same
time, be used as a stepping stone into the
ASCI and the AAP. They should not act as
though they were in the bush leagues. If the
AFCR decided to function on a more inde-
pendent basis than it has in the past, it quickly
could become the group attracting the other
specialties. Emotionally it is still subservient
to the ASCI. For example, in planning their
joint specialty program, the ASCT has first
choice in the selection of papers, the AFCR
second. The ASCI furnished all of its mem-
bers with the 1968 program of the Atlantic
City meetings, including those of the AFCR
and the AAP. But the symposia held Saturday
evening by the AFCR were not mentioned.
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These symposia began only a year ago and be-
came an immediate success. If the AFCR de-
cided to enlarge the scope of its meetings to
run for more than one day they could accom-
modate more groups and sponsor even more
symposia. The age limit of 40 for the officers
is fine. However, there should be no restric-
tion on age for presentation of papers. If a 50
year old physician has done a good piece of
work and can compete effectively with an in-
vestigator in his thirties, why not hear from
the older man too? The young often talk
about restrictions imposed by their elders. They
should not imitate the errors of the elders.
My report is directed to investigators in all
fields of medicine. I hope that it will help
bring them closer together.
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